PBYI Puma Biotechnology

• None no insider bought on the open market
• $97K sold by 1 insider outside a trading plan
• $1.5M sold by 9 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Troy Edward Wilson Director
   Planned sale
   $46K 5,000 shares at $9.10 8.4% of stake
   Traded Sep 14 Filed Sep 16
   ↗
3. Alessandra Cesano Director
   Planned sale
   $567K 62,150 shares at $9.12 52% of stake
   Traded Sep 14 Filed Sep 16
   ↗
4. Troy Edward Wilson Director
   Planned sale
   $78K 10,800 shares at $7.20 15% of stake
   Traded Jun 12 Filed Jun 15
   ↗
5. Brian M Stuglik Director
   Planned sale
   $58K 8,100 shares at $7.20 6.6% of stake
   Traded Jun 12 Filed Jun 15
   ↗
6. Adrian Senderowicz Director
   Planned sale
   $194K 27,000 shares at $7.20 50% of stake
   Traded Jun 12 Filed Jun 15
   ↗
7. Jay M Moyes Director
   Planned sale
   $159K 22,000 shares at $7.22 27% of stake
   Traded Jun 12 Filed Jun 15
   ↗
8. Allison Dorval Director
   Planned sale
   $84K 11,610 shares at $7.20 11% of stake
   Traded Jun 12 Filed Jun 15
   ↗
9. Alan H Auerbach CEO
   Planned sale
   $205K 34,950 shares at $5.86 0.5% of stake
   Traded Jan 6–7 Filed Jan 8
   ↗
10. Douglas M Hunt See Remarks
    Planned sale
    $53K 8,987 shares at $5.86 5.5% of stake
    Traded Jan 6–7 Filed Jan 8
    ↗
11. Maximo F Nougues CFO
    Planned sale
    $64K 10,945 shares at $5.86 5.4% of stake
    Traded Jan 6–7 Filed Jan 8
    ↗
12. Michael Patrick Miller Director
    Sale
    $97K 20,000 shares at $4.86 27% of stake
    Traded Nov 11, 2025 Filed Nov 13, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 10 stock grants, 3 sales to cover taxes, and 1 option exercise.